These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 16809735

  • 1. Formulas calculating creatinine clearance are inadequate for determining eligibility for Cisplatin-based chemotherapy in bladder cancer.
    Raj GV, Iasonos A, Herr H, Donat SM.
    J Clin Oncol; 2006 Jul 01; 24(19):3095-100. PubMed ID: 16809735
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The potential nephrotoxic effects of intensity modulated radiotherapy delivered to the para-aortic area of women with gynecologic malignancies: preliminary results.
    Varlotto JM, Gerszten K, Heron DE, Comerci J, Gautam S, Selvaraj R, Lalonde R, Chura JC.
    Am J Clin Oncol; 2006 Jun 01; 29(3):281-9. PubMed ID: 16755182
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cisplatin-based chemotherapy in renal transplant recipients. A case report and a review of the literature.
    Benisovich VI, Silverman L, Slifkin R, Stone N, Cohen E.
    Cancer; 1996 Jan 01; 77(1):160-3. PubMed ID: 8630924
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A comparison of measured creatinine clearance versus calculated glomerular filtration rate for assessment of renal function before autologous and allogeneic BMT.
    Hahn T, Yao S, Dunford LM, Thomas J, Lohr J, Arora P, Battiwalla M, Smiley SL, McCarthy PL.
    Biol Blood Marrow Transplant; 2009 May 01; 15(5):574-9. PubMed ID: 19361749
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Impact of different methods of estimating renal function on determining eligibility for cisplatin (CDDP)-based chemotherapy in patients with invasive urothelial carcinoma].
    Goto T, Yoshimura K, Matsui Y, Shimizu Y, Inoue T, Okubo K, Kamba T, Nishiyama H, Ogawa O.
    Hinyokika Kiyo; 2011 Dec 01; 57(12):671-6. PubMed ID: 22240299
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction.
    Smilde TD, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL.
    Circulation; 2006 Oct 10; 114(15):1572-80. PubMed ID: 17015793
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.